Recent studies show that the risk of VTE in NHL pts is similar to that observed in high risk solid tumors (i.e. pancreatic, ovarian cancer). VTE in NHL occurs in most cases within three months from diagnosis and can have substantial impact on treatment delivery and outcome as well as on quality of life. However few data are available on potential predictors.
Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL) / Santi, R. M; Ceccarelli, M; Catania, G; Monagheddu, C; Evangelista, A; Bernocco, E; Monaco, F; Federico, Massimo; Vitolo, U; Cortelazzo, S; Cabras, M. G; Spina, M; Baldini, L; Boccomini, C; Chiappella, A; Bari, Alessia; Luminari, Stefano; Calabrese, M; Levis, A; Visco, C; Contino, L; Ciccone, G; Ladetto, M.. - In: THROMBOSIS RESEARCH. - ISSN 0049-3848. - 140 Suppl 1:(2016), pp. S177-S177. [10.1016/S0049-3848(16)30136-0]
Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL)
FEDERICO, Massimo;BARI, Alessia;LUMINARI, Stefano;
2016
Abstract
Recent studies show that the risk of VTE in NHL pts is similar to that observed in high risk solid tumors (i.e. pancreatic, ovarian cancer). VTE in NHL occurs in most cases within three months from diagnosis and can have substantial impact on treatment delivery and outcome as well as on quality of life. However few data are available on potential predictors.
| File | Dimensione | Formato | |
|---|---|---|---|
|
429.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
125.13 kB
Formato
Adobe PDF
|
125.13 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
